Joshua Hare
CIK 1449392 · Chief Scientific Officer · last filed 2025-07-17
Joshua Hare is a Chief Scientific Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for LGVN, was dated Jul 17, 2025. Across all open-market trades the lifetime net is +$795.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $606.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$606.8K
2
24
$795.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LGVN | Chief Scientific Officer | 775,310 | $0.78 | $606.8K | $795.5K | 21 | 2025-07-17 |
| Longeveron Inc. (LGVNR) Delisted | Chief Scientific Officer | 7,828,263 | — | — | $0 | 3 | 2023-09-22 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-17 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | LGVN | Sell (S) | −5,250 | -$7.4K | EDGAR |
| 2025-03-06 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2024-08-19 | LGVN | Grant (A) | +93,766 | $0 | EDGAR |
| 2024-04-12 | LGVN | Buy (P) | +148,936 | $350.0K | EDGAR |
| 2023-12-26 | LGVN | Grant (A) | — | $0 | EDGAR |
| 2023-09-22 | Longeveron Inc. (LGVNR) Delisted | Exer (M) | +5,000 | $15.0K | EDGAR |